IL194434A0
(en )
2011-08-01
Hcv/hiv inhibitors and their uses
HK1210142A1
(en )
2016-04-15
Hcv protease inhibitors and uses thereof hcv
HK1210141A1
(en )
2016-04-15
Hcv protease inhibitors and uses thereof hcv
AP2008004629A0
(en )
2008-10-31
Pseudoinfectious flavivirus and uses thereof
ZA200810323B
(en )
2013-05-29
Fkbp-l and uses thereof
HK1154247A1
(en )
2012-04-13
Hcv nucleoside inhibitor hcv
TWI367115B
(en )
2012-07-01
Novel substrates and uses thereof
SI2185198T1
(en )
2015-04-30
Lox and l0xl2 inhibitors and uses thereof
ZA201001585B
(en )
2010-12-29
Spiropyrrolidines and their use against hcv and hiv infection
PL2064327T3
(en )
2017-10-31
Dbait and uses thereof
EP1906945A4
(en )
2009-07-15
Hcv inhibitors
IL247957A0
(en )
2016-11-30
Anti-ephrinb2 antibofies and methods using same
GB0621160D0
(en )
2006-12-06
Compounds and uses thereof
HK1133552A1
(en )
2010-04-01
Carboranylporphyrins and uses thereof
EP2124908A4
(en )
2011-04-27
Compounds and uses thereof
HK1183623A1
(en )
2014-01-03
Antiviral method and composition
EP2120563A4
(en )
2011-04-27
Compounds and uses thereof
EP1998753A4
(en )
2011-05-04
High-deposition compositions and uses thereof
EP2010141A4
(en )
2011-05-04
High-deposition compositions and uses thereof
GB0600336D0
(en )
2006-02-15
Composition and uses thereof
GB0610059D0
(en )
2006-06-28
Uses and methods
EP2099459A4
(en )
2011-04-27
Compounds and uses thereof
ZA200808226B
(en )
2009-07-29
HCV/HIV inhibitors and their uses
ZA200711069B
(en )
2009-03-25
HCV inhibitors
EP2120957A4
(en )
2011-05-04
Compounds and uses thereof